Effectiveness of the Erchonia EVRL Laser Device for Temporary Relief of Idiopathic Peripheral Neuropathy Foot Pain at Home

What this Trial Is About

Researchers are evaluating the effectiveness of the Erchonia4 EVRL12 for home use to temporarily relieve foot pain caused by idiopathic peripheral neuropathy. This condition causes persistent foot pain without a known cause, and participants must have been diagnosed by a qualified health professional. The study focuses on individuals dealing with ongoing foot pain and aims to understand how well this laser device can reduce pain levels over time. The study involves a single group of participants who will all use the active Erchonia4 EVRL12 device at home. This portable handheld device contains two laser diodes, one red 635 nanometers and one violet 405 nanometers, which are applied approximately 3 to 6 inches above the top of each foot. Participants will self-administer treatments twice daily for 21 days, with each session lasting 5 minutes per foot, totaling 10 minutes per day. During the study, participants will track their pain levels using the Visual Analog Scale and the Neuropathic Pain Symptom Inventory at the start and after 3 weeks. Researchers will monitor changes in pain ratings to measure the devices effect. Participants must follow specific guidelines, including stable pain medication use and avoiding other foot pain therapies during the study. The total participation time spans at least three weeks of treatment and assessment.

Clinical Efficacy of the Erchonia EVRL for Providing Temporary Relief of Idiopathic Peripheral Neuropathy Foot Pain